Therapeutic Drug Monitoring

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Development, Validation, and Application of a Fast and Simple GC–MS Method for Determination of Some Therapeutic Drugs Relevant in Emergency Toxicology
Therapeutic Drug Monitoring - Tập 33 Số 5 - Trang 649-653 - 2011
Markus R. Meyer, Jessica Welter, Achim Weber, Hans H. Maurer
Effects of Salsalate (Nonacetylated Salicylate) and Aspirin on Serum Prostaglandins in Humans
Therapeutic Drug Monitoring - Tập 7 Số 4 - Trang 435-438 - 1985
Helen Morris, Nancy Sherman, Cathy McQuain, Marvin B. Goldlust, Shu-Wen Chang, Lester I. Harrison
An LC-MS/MS Method for Absolute Quantification of Nivolumab in Human Plasma: Application to Clinical Therapeutic Drug Monitoring
Therapeutic Drug Monitoring - Tập 40 Số 6 - Trang 716-724 - 2018
Kei Irie, Akira Okada, Yuta Yamasaki, Chiyuki Kokan, Akito Hata, Reiko Kaji, Keizo Fukushima, Nobuyuki Sugioka, Yutaka Okada, Nobuyuki Katakami, Shoji Fukushima
Background: Nivolumab is a fully humanized IgG4 monoclonal antibody that targets the programmed death-1 (PD-1) receptor, disrupting PD-1–mediated signaling and restoring antitumor immunity. The objective of this study was to develop a nivolumab quantification method using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and to evaluate its application in clinical therapeutic drug monitori... hiện toàn bộ
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions
Therapeutic Drug Monitoring - Tập 42 Số 3 - Trang 360-368 - 2020
Laure Elens, Loralie J. Langman, Dennis A. Hesselink, Stein Bergan, Dirk Jan A. R. Moes, Mariadelfina Molinaro, Raman Venkataramanan, Florian Lemaître
Background: COVID-19 is a novel infectious disease caused by the severe acute respiratory distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently emerging but none with universal consensus or proven efficacy. Solid organ transplant recipients are perceived to be at increased risk of severe COVID-19 because of their immunosuppressed conditions due to chronic use of imm... hiện toàn bộ
Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)
Therapeutic Drug Monitoring - Tập 17 Số 6 - Trang 606-614 - 1995
William J. Jusko, Angus W. Thomson, John J. Fung, P McMaster, Steven Wong, E Zylber-Katz, Uwe Christians, M. Winkler, William E. Fitzsimmons, Ronald Lieberman, James H. McBride, Masakazu Kobayashi, V Warty, Steven J. Soldin
Pitfalls in Monitoring Tacrolimus (FK 506)
Therapeutic Drug Monitoring - Tập 19 Số 6 - Trang 628-631 - 1997
Felix Braun, Ekkehard Schütz, Uwe Christians, T Lorf, J H Schiffmann, V W Armstrong, W. Schröter, Karl–Friedrich Sewing, Michael Oellerich, B. Ringe
Receptor (Immunophilin-Bhiding) Assay for Immunosuppressive Drugs
Therapeutic Drug Monitoring - Tập 17 Số 6 - Trang 574-576 - 1995
S J Soldin
Analysis of Tacrolimus (FK 506) in Relation to Therapeutic Drug Monitoring
Therapeutic Drug Monitoring - Tập 17 Số 6 - Trang 596-601 - 1995
Jusko Wj
Methods for Quantification of Exposure to Cigarette Smoking and Environmental Tobacco Smoke: Focus on Developmental Toxicology
Therapeutic Drug Monitoring - Tập 31 Số 1 - Trang 14-30 - 2009
Ana Florescu, Roberta Ferrence, Tom Einarson, Peter Selby, Offie P. Soldin, Gideon Koren
Relationship Between Oral Fluid and Blood Concentrations of Drugs of Abuse in Drivers Suspected of Driving Under the Influence of Drugs
Therapeutic Drug Monitoring - Tập 31 Số 4 - Trang 511-519 - 2009
Sarah M. R. Wille, Elke Raes, Pirjo Lillsunde, Teemu Gunnar, Marleen Laloup, Nele Samyn, Asbjørg S. Christophersen, Manfred R. Moeller, Karin Hammer, Alain Verstraete
Tổng số: 69   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7